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Abstract 
Background: About 10% of the mouse genome is composed of endogenous retroviruses (ERVs) that represent a 
molecular fossil record of past retroviral infections. One such retrovirus, murine ERV‑L (MuERV‑L) is an env‑deficient 
ERV that has undergone episodic proliferation, with the most recent amplification occurring ~ 2 million years ago. 
MuERV‑L related sequences have been co‑opted by mice for antiretroviral defense, and possibly as promoters for 
some genes that regulate totipotency in early mouse embryos. However, MuERV‑L sequences present in modern 
mouse genomes have not been observed to replicate.
Results: Here, we describe the reconstruction of an ancestral MuERV‑L (ancML) sequence through paleovirologi‑
cal analyses of MuERV‑L elements in the modern mouse genome. The resulting MuERV‑L (ancML) sequence was 
synthesized and a reporter gene embedded. The reconstructed MuERV‑L (ancML) could replicate in a manner that is 
dependent on reverse transcription and generated de novo integrants. Notably, MuERV‑L (ancML) exhibited a narrow 
host range. Interferon‑α could reduce MuERV‑L (ancML) replication, suggesting the existence of interferon‑inducible 
genes that could inhibit MuERV‑L replication. While mouse APOBEC3 was able to restrict the replication of MuERV‑L 
(ancML), inspection of endogenous MuERV‑L sequences suggested that the impact of APOBEC3 mediated hypermu‑
tation on MuERV‑L has been minimal.
Conclusion: The reconstruction of an ancestral MuERV‑L sequence highlights the potential for the retroviral fossil 
record to illuminate ancient events and enable studies of the impact of retroviral elements on animal evolution.
© The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Uniquely among animal viruses, retroviruses integrate 
into the genome of the host cell as an obligate step in 
their replication cycle. Because the target cells of some 
retroviruses can include cells of the germ line, proviruses 
can occasionally become vertically inherited [1]. A sub-
set of these inherited proviruses can become fixed in the 
population through genetic drift, or sometimes by pro-
viding an evolutionary advantage to the host. Inherited 
proviruses are termed endogenous retroviruses (ERVs) 
and are present in all animal species that have been 
examined, accounting for approximately 8 and 10% of the 
human and mouse genomes, respectively [2]. In nearly 
every case, however, fixed proviruses have inactivating 
mutations that prevent their further spread.
The vast array of ERVs represent an extensive viral fos-
sil record that provides an opportunity to study the biol-
ogy of ancient or extinct retroviruses, and the effects that 
these viruses have had on the evolution of their hosts 
[3]. Previously, we and others have reconstructed a full-
length infectious human ERV (HERV-K) [4, 5], functional 
capsid proteins of endogenous chimpanzee gammaret-
roviruses (CERV 1 and 2) [6, 7], and lentiviruses, PSIV 
and RELIK [8], as well as functional envelope proteins 
from CERV2 and HERV-T [9, 10]. These reconstruction 
experiments have enabled the identification of ancient 
virus receptors [9, 10] and demonstrated the ancient 
origin of cyclophilin A-lentiviral capsid interactions [8]. 
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Additionally, these studies have shown that the replica-
tion of HERV-K, CERV1 and CERV2 was affected by the 
APOBEC3 cytidine deaminases [5, 6, 11]. Overall these 
“paleovirological” studies have provided previously inac-
cessible insights into the co-evolution of viruses and 
hosts.
Murine ERV-L (MuERV-L) is an abundant mouse ERV 
that is transcriptionally active at an early (2-cell) stage 
of the mouse embryo [12–15]. Previous analyses have 
established that MuERV-L underwent two amplification 
bursts, one after the divergence of the Mus and Rattus 
genera around ~ 10 million years ago (MYA), and a more 
recent and prolific burst about 2 MYA, which is distin-
guished by the presence of a 33nt in-frame deletion in 
the 5′ half of the gag ORF (Fig.  1a) [16]. These amplifi-
cations led to the deposition of thousands of MuERV-
L derived sequences in the mouse genome. Moreover, 
MuERV-L belongs to a larger family of ERV-L elements 
that have been active throughout the evolution of mam-
mals [17–19]. In contrast to their human counterparts, 
many MuERV-L elements have complete coding poten-
tial, encoding open reading frames (ORFs) for gag and 
pol (Fig.  1a) [20]. However, like other ERV-L elements, 
MuERV-L is characterized by the complete absence of 
an env gene that, coupled with its highly restricted early 
transcription profile, suggests an entirely intracellu-
lar retrotransposon-like replication cycle [21]. Indeed, 
MuERV-L transcripts are able to give rise to intracellu-
lar viral-like particles that accumulate in the endoplas-
mic reticulum [13] but are not thought to be replication 
competent.
MuERV-L related or derived sequences appear to have 
been co-opted for two distinct biological activities in the 
mouse. The antiretroviral restriction factor Fv1, which 
inhibits infection by MuLV and certain other retrovi-
ruses is derived from MuERV-L-like Gag sequences and 
appeared in the mouse genome at least 5 MYA [22–24]. 
Additionally, recent studies have suggested that the 
propensity of MuERV-L to be transcriptionally active 
only at the two-cell stage of mouse embryogenesis may 
have led to the co-option of its long terminal repeats 
(LTRs), as promoters of genes involved in the zygotic 
genome activation [14, 15]. Transcriptional activity of 
MuERV-L LTRs in two-cell mouse embryos may drive 
the expression of hundreds of genes that contribute to 
the totipotency of the blastomeres, but also results in the 
expression of MuERV-L Gag–Pol polyprotein and the 
formation of intracellular viral-like particles [13–15]. As 
development progresses, MuERV-L LTRs appear to be 
silenced [14, 25, 26]. The expression of MuERV-L at the 
two-cell stage does not induce an increase in their copy 
numbers, suggesting that the expressed proviruses do not 
have the potential to re-integrate into the genome [25].
In fact, no extant copy of MuERV-L has been demon-
strated to be capable of completing a replication cycle. 
Therefore, we set out to derive a replication-competent 
MuERV-L, based on the premise that an ancestral recon-
struction would deliver a sequence that most closely 
resembles that of a functional ancestor. Herein, we 
describe the analysis of MuERV-L elements in the mouse 
genome, a successful reconstruction of a ~ 2MY old rep-
lication-competent ancestral sequence and an analysis of 
its replication and its interaction with the components of 
the host intrinsic/innate immune systems.
Methods
Bioinformatic analyses and ancestral reconstruction
Screening for MuERV-L elements was performed using 
amino acid and nucleotide sequences from the MuERV-L 
reference sequence (MuERV-Lref, GenBank: Y12713) [20] 
as probes for tBLASTn (gag and pol) and BLASTn (LTR) 
[27] searches of two mouse genome assemblies: Mm_
Celera (NCBI: GCF_000002165.2) [28] and GRCm38/
mm10 (UCSC: mm10) [29]. To avoid the identification of 
sequences from related but distinct retroviruses, BLAST 
hits with an e-value ≤ 1e−10 were used as probes for a 
second round of BLASTx or BLASTn searches against a 
previously constructed database of endogenous and exog-
enous class III retroviral sequences. Results from these 
BLAST searches were imported into a relational database 
to facilitate the management of the screening process and 
analysis of hits. Reciprocal hits to MuERV-Lref were first 
ordered by chromosome and orientation and then adja-
cent or overlapping hits were assembled into proviral loci 
by comparison with the MuERV-Lref sequence, allowing 
for insertions no longer than 10,000 nucleotides. The 
resulting MuERV-L loci were annotated as genomic fea-
tures of GRCm38 (downloaded from Ensembl [30] using 
BioMart) by comparison of their chromosome location 
using in-house Perl scripts.
Dates of integration for MuERV-L elements were esti-
mated by determining the divergence (K) to a consensus 
sequence (for solo LTRs) or between paired LTRs (for 
provirus-containing loci) using PAUP* [31], divided by 
2× the mouse neutral substitution rate (r) of 4.5 × 10−9 
substitutions per site per year [29] (K/2r) [32, 33]. The 
mean sequence identity between the consensus LTR 
sequence and each of the solo LTRs was 95.43%, with 
very few outliers (1.5% of solo LTRs showed less than 
80% identity), suggesting that the consensus sequence 
is adequate to perform these estimations. Nevertheless, 
the estimated ages derived using this method represent 
approximations to the integration dates and should be 
treated as such.
Statistical analyses of the positions of MuERV-
L elements relative to mouse genomic features were 
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performed using the Pearson’s Chi-squared test for count 
data (chisq.test) implemented in R. As controls, two 
sets of random coordinates in the mouse genome were 
computationally generated using in-house Perl scripts 
and the runif function implemented in R. For solo LTR 
comparisons, 10,000 random mouse sequences of 500 
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Fig. 1 Structure and distribution of MuERV‑L elements in the mouse genome and reconstruction of an ancestral ~ 2MY old MuERV‑L sequence. a 
Schematic representation of the structure of MuERV‑L elements. White boxes in gag represent the 33 and 39nt deletions in gag at nucleotide posi‑
tions 671 and 1597, respectively. b Distribution of distinct MuERV‑L structures among mouse chromosomes.  YS = Y chromosome short arm,  YL = Y 
chromosome long arm. c Distribution of MuERV‑L elements in mouse genomic features (GRCm38/mm10). The fraction of the 2971 elements inside 
and outside genes is depicted (top chart), as the fraction of elements present in each type of gene or gene feature (bottom chart). d Distribution of 
MuERV‑L elements in genic or intergenic regions relative to random controls. The measured value indicates the percentage of MuERV‑L elements 
in each population divided by that of the random controls (see “Methods”). The horizontal dotted line indicates no difference between the ratio of 
MuERV‑L elements in each population and that of the controls. (*) p value < 0.05. (***) p value < 0.001. P values are based on Chi‑squared goodness‑
of‑fit or contingency table tests. e Maximum likelihood phylogenetic tree of 95 LTR–gag–pol–LTR MuERV‑L elements in the mouse genome. Arrow 
denotes the ancestral node reconstructed by baseml (pol and LTR, node 96). f Maximum likelihood phylogenetic tree of 230 gag–pol containing 
MuERV‑L elements in the mouse genome. The monophyletic red clade contains only elements with a 33nt deletion in gag at position 671 with or 
without an additional 39nt deletion in gag at position 1597. Arrow denotes the ancestral node reconstructed by baseml (gag, node 377)
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nucleotides in length were generated. For proviral loci 
comparisons, 5000 random mouse sequences of 6500 
nucleotides in length were generated. The coordinates of 
both MuERV-L integrations and random sequences were 
then mapped to the GRCm38 genome assembly to deter-
mine overlapping genomic features (intergenic regions, 
genes, common repeats and others) using in-house Perl 
scripts. For ancML integration comparisons, in-house 
Perl scripts were used to generate controls, consisting 
of 1000 randomly selected EcoRV-containing fragments 
(of 1000 nucleotides in length) from the Chinese hamster 
genome. Each ancML integration site was matched with 
three of these genomic sequences such that control sites 
were equidistant from an EcoRV site as was each ancML 
integration site, as described in [34]. These sites were 
then mapped to the Chinese hamster genome (criGri1) 
[35] to determine the overlapping genomic features.
Ancestral reconstruction of MuERV-L was performed 
using two distinct sequence sets. For the reconstruction 
of the ancestral pol gene and the LTRs, we used a set of 
95 complete proviral sequences (LTR–gag–pol–LTR) 
identified by default-parameter based BLASTn searches 
of GRCm38 using MuERV-Lref. Each proviral sequence 
was individually aligned to MuERV-Lref using MUSCLE 
[36] and a multiple sequence alignment (MSA) was gen-
erated using the profile alignment function of MUSCLE. 
Insertions relative to MuERV-Lref were eliminated from 
the MSA, except a 6nt insertion at position 298 and 
6249 in both LTRs that was shared between 25% of the 
sequences. The MSA was used to construct a maximum 
likelihood (ML) phylogenetic tree using raxML [37] with 
the following parameters: rapid bootstrap analysis with 
1000 replicates under GTRCAT followed by a ML search 
under GTRGAMMA to evaluate the final tree topology 
(-m GTRCAT -# 1000 -x 13 -k -f a). Thereafter, the tree 
was midpoint rooted. The MSA together with the phylo-
genetic tree were used to guide an ML ancestral recon-
struction using baseml from the PAML package [38] 
(model: REV, initial values of alpha and kappa were calcu-
lated on the MSA by jmodeltest [39], branch lengths were 
used as initial values). For the ancestral reconstruction of 
the gag ORF we first aligned and constructed a phyloge-
netic tree using 230 gag–pol containing sequences (iden-
tified by our screening of the mouse genome described 
above). We determined the presence or absence of the 33 
and 39nt deletions in the gag ORF relative to MuERV-Lref 
(that does not show any deletion) and identified a mono-
phyletic clade of 40 sequences that had the 33nt deletion 
in gag (irrespective of the status of the 39nt deletion). 
Thereafter, reconstruction of the ancestral gag sequence 
corresponding to the internal node for this monophyletic 
clade was performed as described above. A correction 
for the effect of methylation-induced mutations at CpG 
dinucleotides was applied on both strands of all three 
sequences (gag, pol and LTR) as described in [8]. Specifi-
cally, if a particular site where the ancestral reconstruc-
tion estimated a TG dinucleotide but at least 10% of the 
sequences in the MSA encoded a CG at that position, the 
TG state was considered to be the result of methylation-
induced mutation and the sequence at this position was 
assigned as CG. The resulting sequences were combined 
to produce the sequence from which ancML was derived.
Hypermutation analysis and statistics were performed 
using Hypermut 2.0 [40] on the set of 230 gag–pol con-
taining sequences used to reconstruct an ancestral gag, 
using either default parameters or with exclusion of sites 
with a 5′ C next to the mutated G.
Plasmid construction
To construct ancML, sequences from the U3 region of 
the MuERV-L 5′LTR 5′ to the TATA box were substituted 
with corresponding CMV promoter sequences. We also 
added an extra 12nt containing two MluI sites immedi-
ately 3′ to the pol stop codon to facilitate the insertion 
of a reporter gene. The modified ancML sequence was 
synthesized and inserted into pUC57 (Genewiz, NJ). The 
replication dependent LINE-1 element (L1.3 plasmid) 
[41] was kindly provided by Dr. John V. Moran. The rep-
lication dependent neo cassette (a neo gene controlled 
by a SV40 promoter and interrupted by an intron) was 
amplified by PCR from the L1.3 plasmid and inserted 
into ancML using the MluI sites at the 3′ end of pol. A 
separate pCR3.1 based plasmid, expressing GFP (from a 
CMV promoter) and a neo gene (NEO, expressed from a 
SV40 promoter) was used as a control.
The ancML-RTmut construct was created by using 
overlapping PCR and primers that annealed to the RT 
active site with four nucleotide mismatches, the PCR 
fragment was inserted into ancML using unique sur-
rounding BstZ17I and NheI restriction sites contained 
in the outmost primers, generating an ancML with a 
mutated RT active site (YIDD to AIAA).
The ancML∆GAAGT construct was generated using 
PCR and a reverse primer that annealed to the 5′ end of 
the PBS and the 3′ end of the U5 region of the 5′LTR, and 
lacked the intervening 5nt linker sequence (GAAGT). 
The PCR fragment was inserted into ancML using unique 
AgeI and KpnI restriction sites contained in the forward 
and reverse primers, respectively.
A plasmid expressing mouse APOBEC3 (mA3, 
C57BL/6J strain) was kindly provided by Rachel Libera-
tore (unpublished). A C-termini HA-tagged version of 
mA3 was produced by PCR using primers containing two 
HA tags and a 15nt linker sequence, following previously 
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published functional human HA-tagged APOBEC3 pro-
teins [42, 43]. This construct was introduced into the ret-
roviral expression plasmid LBCX using unique SfiI sites. 
A retroviral vector (LBCX) expressing  Fv1bbn was kindly 
provided by Dr. Theodora Hatziioannou [44].
Cell culture
Cell lines (except CHO-K1 and pgsA cells) were main-
tained in Dulbecco’s Modified Eagle Medium (DMEM), 
Eagle’s Minimum Essential Medium (EMEM) or Roswell 
Park Memorial Institute medium (RPMI) supplemented 
with 10% FBS and gentamycin (2 µg/ml, Gibco) accord-
ing to ATCC instructions. CHO-K1 and pgsA cells were 
maintained in Ham’s F-12 media supplemented with 10% 
FBS, 1  mM of l-glutamine and 2  µg/ml of gentamycin. 
All cells were incubated at 37  °C, except DF-1 cells that 
were incubated at 39 °C.
Generation of CHO cell lines expressing murine APOBEC3
293T cells were transfected (using polyethylenimine) 
with plasmids expressing MuLV gag–pol, and VSV-G, 
along with an LBCX based retroviral vector expressing 
HA-tagged mA3 or  Fv1bbn. Viral stocks were harvested 
and filtered (0.22  μm) 2  days after transfection, and 
were used to transduce CHO-K1 cells (seeded in 24 well 
plates). Transduced cells were expanded in 10 cm dishes 
with media supplemented with 5  μg/ml of blasticidin 
(Thermo Fisher Scientific Inc.). Single cell clones express-
ing mA3 were isolated by seeding blasticidin resistant 
cells at 0.5 cells per well in a 96 well plate. Three distinct 
single clones that expressed mA3 in 100% of the cells 
(tested by immunofluorescence) were used in ancML 
replication assays.
Immunofluorescence assay
Individual clones of CHO cells expressing murine 
APOBEC3 were fixed with 4% paraformaldehyde (PFA) 
for 30  min followed by treatment with 10  mM glycine 
(diluted in PBS) for another 30 min. Cells were perme-
abilized with a buffer containing 0.1% of Triton X-100 
and 5% goat serum (diluted in PBS) for 15  min. Cells 
were then washed 2 times with PBS before being treated 
with mouse monoclonal anti-HA antibody (Covance) 
diluted in a buffer containing 0.1% Tween-20 and 5% 
goat serum (diluted in PBS) for 2  h at room tempera-
ture. Cells were washed three times with PBS before 
being treated with goat anti-mouse secondary antibody 
(Alexa Fluor 488 dye, ThermoFisher) diluted in a buffer 
containing 0.1% Tween-20 and 5% goat serum (diluted 
in PBS) for 1 h at room temperature. Cells were washed 
three more times with PBS and fluorescent microscopy 
images were analyzed using the EVOS FL Cell Imaging 
System.
MuLV infection assay
293T cells were transfected (using polyethylenimine) 
with plasmids expressing N-tropic or B-tropic MuLV 
gag–pol, and VSV-G, along with a CNCG based retro-
viral vector expressing GFP [45]. Viral stocks were har-
vested 2  days after transfection, filtered (0.22  μm) and 
were used to infect control or  Fv1bbn-expressing CHO 
cells. Two days post infection the percentage of GFP pos-
itive population was quantified using the Guava EasyCyte 
flow cytometer (Millipore).
MuERV‑L(ancML) replication assays
The cell lines listed in Table  2 were seeded in 12 well 
plates  1  day before being transfected with 700  ng of 
plasmids containing L1.3, ancML or a plasmid express-
ing gfp and a neo gene, using 4 μl of Lipofectamine 2000 
(Thermo Fisher Scientific Inc.) according to manufac-
turer instructions. Two days after transfection, cells were 
plated in 6-well plates with G418 selection media (con-
taining concentrations of G418 that were previously cali-
brated for each cell type). Ten days later, surviving cells 
were fixed with 4% PFA and colonies were stained using 
0.3% crystal violet in 20% ethanol for counting.
Subsequently, the ancML replication assays were rou-
tinely done using CHO-K1 cells as follows. CHO-K1 cells 
were seeded at 3 × 105  cells per well in a 12 well plate. 
One day later the cells were transfected with 1 μg of plas-
mid DNA, using 3 μl of Transit-CHO supplemented with 
0.5  μl of CHO-mojo reagent (Mirus) diluted in Opti-
MEM (Gibco). One day later, the cells were expanded on 
a 10 cm dish with media supplemented with or without 
AZT (obtained through the NIH AIDS Reagent Program, 
Division of AIDS, NIAID, NIH) or mouse IFNα (Pestka 
Biomedical Laboratories, Inc.). Two days later, cells were 
plated in a 15 cm dish or three 96 well plates (for analy-
sis of single cell clones) with media supplemented with 
1 μg/ml of G418. For controls, 1/1000 of the cells trans-
fected with the NEO plasmid were plated in the 15  cm 
dish with selection media. Cells in 15  cm dishes were 
cultured under selection for 10  days before treatment 
with 4% PFA and colonies were stained with 0.3% crystal 
violet in 20% ethanol for counting. Single colonies in 96 
well plates were monitored and expanded until reaching 
confluence in a 10 cm dish. Genomic DNA (gDNA) was 
extracted from 5 × 106 cells using QIAmp DNA mini kit 
(QIAGEN) for analysis of ancML integration (see below).
To determine the fate of the intron interrupting the neo 
gene during ancML replication, gDNA extracted from 
CHO pools of cells transfected with a plasmid expressing 
ancML, ancML∆GAAGT or an empty vector, was used 
as template for PCR analysis. Forward and reverse prim-
ers were design to anneal to the extreme 5′ and 3′ ends 
of the neo gene. For all PCRs performed in this study we 
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used Phusion High-Fidelity DNA Polymerase (Thermo 
Fisher Scientific Inc.).
Integration site analyses
Sites of ancML integration were determined using a uni-
versal Genome Walker kit (Clontech). Briefly, gDNA was 
extracted from expanded single cell clones of CHO cells 
following transfection with a plasmid containing ancML 
and selected in G418. The gDNA was digested with 
EcoRV (New England Biolabs) and ligated to adaptors. 
Nested PCRs were performed using forward primers 
that were designed to anneal to the R region of the 3′LTR 
and the reverse primers to the adaptor sequence, thereby 
amplifying 3′ flanking sequences. Bands from second 
round PCR reactions were gel purified and inserted into 
pCR-Blunt II-TOPO using the Zero Blunt TOPO PCR 
cloning Kit (Life technologies) for sequencing. To amplify 
and sequence the 5′ flanking site we use reverse primers 
specific to the 5′ LTR and designed forward primers that 
would specifically anneal to the predicted integration site, 
based on the previously sequenced 3′ flanking sequence. 
The resulting CHO gDNA sequences were mapped to the 
CHO genome (criGri1) using BLAT [46] searches on the 
UCSC genome browser [47]. To account for biases due to 
location and density of EcoRV restriction sites, we com-
pared the distribution of the 26 ancML integration sites 
to matched random controls consisting of three random 
genomic locations that were at the same distance from an 
EcoRV site as the site found in the flanking CHO DNA 
sequence for each MuERV-L integration site [34] (see 
above).
Results
Bioinformatic screens for MuERV‑L elements in the mouse 
genome
To construct a replication-competent MuERV-L 
sequence we first catalogued the diversity of MuERV-
L related sequences in the mouse genome. Currently, 
there are two available complete mouse genome assem-
blies: the Mouse Genome Reference Consortium build 
38 (GRCm38 also known as mm10) corresponding to 
the C57BL/6J strain [29], and the whole genome shotgun 
(WGS) assembly (Celera) that corresponds to a mixture 
of 5 strains (129X1/SvJ, 129S1/SvImJ, DBA/2J, A/J and 
C57BL/6J) [28]. We mined both genome assemblies using 
BLASTn and tBLASTn [27] searches with separate gag, 
pol and LTR probes from a MuERV-L reference sequence 
(GenBank: Y12713) [20]. The resulting hits were defrag-
mented by merging contiguous hits that mapped to the 
same locus, representing individual elements.
Overall, we found nearly 3000 MuERV-L elements in 
the mouse genome that had three major types of struc-
tures (Table  1, Fig.  1b, Additional file  1: Table S1). One 
type comprised complete or near complete proviruses, 
consisting of an internal gag–pol region flanked by two 
LTRs. The frequency with which this structure occurred 
was highly discrepant in the two genome assemblies, 
with 220 proviruses being present in the Celera assem-
bly and 719 in GRCm38 (Table 1). It is unclear whether 
this discrepancy is due to the different mouse strains or 
the assembly methods used in each genome project. A 
second type of MuERV-L elements were solo LTRs that 
typically arise from recombination between the LTRs 
flanking a provirus, resulting in the complete excision of 
the internal sequence. This type of element represents 
the single most abundant ERV type in animal genomes 
and accounts for > 50% of the MuERV-L elements in 
the mouse genome (Table 1). The third type of MuERV-
L structures, representing ~ 25% of all elements, were 
composed of internal sequences with or without a single 
associated LTR (Table 1).
Because the GRCm38 assembly was better supported 
by external and internal annotations we utilized this 
data source to analyze the distribution of MuERV-L ele-
ments in the genome (Fig.  1b–d). MuERV-L elements 
were roughly evenly distributed across mouse chromo-
somes (Fig.  1b), with the exception of the Y chromo-
some in which MuERV-L was underrepresented. Indeed, 
there were only a few elements in the Y chromosome. 
This finding was surprising, given that other ERVs, (e.g. 
HERV-K) are enriched in the human Y chromosome [48]. 
However, in contrast to human Y chromosome, the long 
arm of the mouse Y chromosome is a highly dynamic 
gene rich region that has frequently expanded and under-
gone rearrangement over the past ~ 3 MY [49]. The 
distribution of MuERV-L elements in this mouse chro-
mosome shows a clear discrepancy between the short 
and long arms (Fig. 1b). This finding is likely explained by 
the low recombination rate of the short arm of the mouse 
Y chromosome, resulting in an enrichment of mobile 
DNA elements, while recent gene amplification and 
Table 1 MuERV-L sequences identified in mouse genome assemblies
Assembly Strain References Total soloLTR Provirus Fragments
GRCm38 C57BL/6J [29] 2971 1588 719 664
Mm_Celera Mixture [28] 2768 1775 220 773
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rearrangement events in the long arm may have inhibited 
the fixation of MuERV-L elements.
The majority (79%) of MuERV-L elements were found 
in intergenic regions (Fig. 1c). About ~ 19.5% of elements 
were found inside introns (Fig. 1c), of which the major-
ity (65%) were found in antisense orientation relative to 
of the corresponding gene, as previously documented for 
Intracisternal A particles (IAPs) [50]. The remaining ele-
ments (1.5%) were found primarily in non-coding RNA 
genes and untranslated exons (UTRs, Fig.  1c). Only 10 
LTRs were found overlapping coding exons. This dis-
tribution differs significantly compared to randomized 
controls (p < 0.001). This enrichment of elements outside 
genes was also apparent if analysis was confined to solo 
LTRs (p value < 0.001, Fig.  1d) or if proviruses from the 
2MYA or 10MYA expansions were analyzed separately 
(p values < 0.05, Fig. 1d). Overall, these observations are 
consistent with an expected selective pressure against 
retention of MuERV-L elements in genes, which was less 
evident for younger loci (2nd expansion, Fig. 1d). Inter-
estingly, 10.13% of proviruses implicated in the 10MYA 
expansion have lost a recognizable ORF (either gag or 
pol), in contrast to integrations implicated in the 2MYA 
expansion where only 5.02% have lost an ORF, consistent 
with the notion that a modest selection to purge MuERV-
L sequences is ongoing.
Reconstruction of an ancestral MuERV‑L
To reconstruct the ancestral MuERV-L LTRs and the 
pol ORF, we selected 95 complete (LTR–gag–pol–LTR) 
proviruses that were most closely related to a reference 
MuERV-L sequence (defined by BLAST searches), as this 
sequence has retained coding potential for both ORFs, 
has almost identical LTRs, and contained recognizable 
functional motifs [20]. These sequences were used to 
guide a maximum likelihood (ML) reconstruction of the 
root node (pol n96) and a pair of identical LTRs (Fig. 1e).
For reconstruction of the Gag gene we took a slightly 
different approach. As the 2nd expansion was the most 
prolific and we expected that younger integrations would 
be less divergent from a functional ancestor than older 
integrations, we selected gag sequences that were spe-
cific to the most recent expansion (based on the presence 
of the 33nt in-frame deletion in gag). After aligning 230 
gag–pol containing loci that were present in both Celera 
and GRCm38 assemblies to the reference sequence (that 
does not exhibit the deletion), we identified a monophy-
letic clade of 40 elements that all contained a 33nt in-
frame deletion in the 5′ half of their gag ORFs (Fig. 1f ). 
The gag sequences in this clade were selected to guide 
a ML reconstruction of this internal node (gag n377). 
Thereafter, the combined ancestral LTR, gag and pol 
ancestral sequences were corrected for probable errors 
derived from deamination of methylated CpG dinucleo-
tides to create a ~ 2 MY ancestral MuERV-L sequence 
(ancML, Fig. 2 and Additional file 2) (see “Methods”).
ancML is replication‑competent and its replication is 
dependent on a functional reverse transcriptase
To assess the potential replication competence of the 
reconstructed ancestral MuERV-L sequence, we inserted 
the full-length ancML sequence into a plasmid vector, 
replacing the U3 region of the 5′ LTR by a CMV pro-
moter to overcome the highly restricted promoter activ-
ity of the MuERV-L LTR (Fig. 3a). This design allows for 
the loss of the CMV promoter sequence after transcrip-
tion, reverse transcription and integration, resulting in 
two identical flanking LTRs. A replication-dependent 
reporter gene, consisting of a neo gene controlled by a 
separate SV40 promoter and interrupted by an intron, 
was inserted between pol and the 3′ LTR (Fig. 3a). While 
the SV40p-neo cassette is in reverse orientation relative 
to ancML transcription, the splice donor and accep-
tor sites of the intron are in the same orientation as the 
ancML transcription. Thus, only if ancML undergoes 
splicing, reverse transcription and integration in the host 
cell genome the intron is removed and a functional Neo 
(G418 resistance) protein is expressed. This approach has 
been used previously to monitor the intracellular replica-
tion of retrotransposons [51].
We determined whether transfection of a plasmid har-
boring ancML could produce G418 resistant colonies in 
cultured cell lines. For this purpose we tested a set of 13 
cell lines: 6 of primate origin, 5 from rodents, 1 from a 
carnivore and 1 from an avian species (Table 2). Despite 
efficient transfection in the majority of the cells tested, 
and the abundant formation of G418-resistant colonies 
using a control plasmid, the ancML expression plasmid 
was able to generate G418 resistant colonies only in 
Chinese hamster ovary K1 (CHO) cells, CHO-derived 
pgsA cells, and (to a greatly reduced extent) in Vero 
cells (Table  2 and Fig.  3b). Surprisingly, a control plas-
mid expressing a LINE1 element containing the same 
replication dependent neo resistant gene (L1.3 plasmid) 
[41] failed to produce G418 resistant colonies in 4 of the 
cells tested, including Vero (Table 2). Conversely, all the 
cell lines tested generated G418 resistant colonies when 
transfected with a control plasmid expressing an intact 
neo gene.
To determine whether the ancML-associated G418 
resistant colonies had arisen as a result of ancML repli-
cation, we mutated the predicted ancML reverse tran-
scriptase (RT) active site from YIDD to AIAA (Fig.  2). 
This mutation completely abolished the production 
of G148 resistant colonies following ancML transfec-
tion (Fig. 3c). Additionally, we found that the formation 
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1 TGTAGTGGCTATTCCTGGTTGTCAACTTGACAATATTTGGAATGAACTACAATCCGGAATTGGAAGGCTCACCAGTGACCCTTATCTGGAGGCTTGGAGATCCTTATCTGGATCTTGGTATGGAGATCT
130 TGAGCCATAGTGGCTATGGATTCCAGAAGATTGAATCTCCGAGTTTAAGGAACACACCTTTAATCTGGGCTACGCCTTTCATCTGGGATTAAAGGTGTGGTGGAACACACCTTTAATCTGGGCTACACC
259 TTCTGCTGGAGACAATATAAGGACATTGGAAGAAGGGAGTCTAGCTCTAGCTCTTGCTCTTGCTCCTTCGCCTGCTTGCTGCGTGAGACTGAGTAACTGCTAGATCCTTGGACTTCCATTCACAGCTGC
388 GACTGAACAATTGTTGGGAATTGGGCTGCCGACTGTAAGTCATCAATAAATTCCTTTACTATCTAGAGACTATCCATAAGTTCTGTGACTCTAGAGAACCCTGACTAATACAGAAGTTGGTACCAGGAG
517 TGGTTCTAGAGTAACAGAAGTACAAGGATGAATCTTTTAAAATTCTGGAATTGGCTTGTTGATCCACCAGCACTTTCAACTATTGAAACCTCTCCAGATTCTCTCCCTCCTGGGAGCTCAGAGAATTTT
1 M N L L K F W N W L V D P P A L S T I E T S P D S L P P G S S E N F
646 GAAGACCCATGGTTGAAACTATATTCCGAACTTAAAGAAGCTAATGCCCTTGATTTTCTTAATGAATTAGGTGATTCAGTGCACAAAGCTTTCTACAAGATGGGGAAAAAATCGAAAAATGATTTTACT
35 E D P W L K L Y S E L K E A N A L D F L N E L G D S V H K A F Y K M G K K S K N D F T
775 GGCTGGCTGCTCTTAGTATCTGTGGAAAAAATGATGAATGAAAGGAAGGAGTTGTGTGATAAAATCGAAAGGCTCCAGACACAAGTAAACGATCTAAAAGTTGCTAAGTGTGTCCTTGAGGAGAATCTT
78 G W L L L V S V E K M M N E R K E L C D K I E R L Q T Q V N D L K V A K C V L E E N L
904 CTCTCTTGTAGCAATAGAGCTCAAGTTGCAGAAAATCAAACAGAAACTCTCATTGTAAGGTTGGCTGAACTACAGCGAAAATTCAAGTCTCAGCCTCAGAGTGTGTCGACAGTTAAAGTAAGGGCTCTA
121 L S C S N R A Q V A E N Q T E T L I V R L A E L Q R K F K S Q P Q S V S T V K V R A L
1033 ATTGGCAAAGAATGGGATCCTACAACATGGGACGGGGATGTGTGGGAAGACCATGTTGAAGCTGAGAATTTTGAATCCTCAGATTCTCAAGGGTTTGCCCCACCTGAGGAAGTAGTACCCTCAGCCCCA
164 I G K E W D P T T W D G D V W E D H V E A E N F E S S D S Q G F A P P E E V V P S A P
1162 CCTCTTGAAATAATGCCTTCCCCACATGAGGAAATTAATTTTGCAGAGTCTGCTCACGGCCCACCAATAGTTTCTTCTAGACCTGTAACCAGACTCAAAGCAAAACAGGCTCCTAGAGGGGAGGTAGAA
207 P L E I M P S P H E E I N F A E S A H G P P I V S S R P V T R L K A K Q A P R G E V E
1291 AGTGTAGTCCATGAGGAAATTCGCTACACTACTAAGGAGCTTAATGAGTTTGCTAATTCATTCAAGCAGAAACCTGGTGAATATGTGTGGGAATGGATTTTAAGGGTGTGGGATAAGGGTGGAAGGAAC
250 S V V H E E I R Y T T K E L N E F A N S F K Q K P G E Y V W E W I L R V W D K G G R N
1420 ATAAAACTAGAGCAGGCTGAGTTTATTGACATGGGTCCTCTGAGTAGAGATTCTAGGTTTAATACGGAAGCTCGCATAGTTAAAAAAGGTGTCAAAAGTTTGTTTGAATGGTTGGCTGAGGTGTTTATC
293 I K L E Q A E F I D M G P L S R D S R F N T E A R I V K K G V K S L F E W L A E V F I
1549 AAAAGATGGCCTACTGGAAATGACTTGGAGATGCCTGATATTCCGTGGCTTAGTGTTGATGAAGGGATTTTAAGACTTAGGGAAATTGCAATGCTAGAGTGGATATATTGTGTAAAGCATAATTGTCCA
336 K R W P T G N D L E M P D I P W L S V D E G I L R L R E I A M L E W I Y C V K H N C P
1678 CAATGGGAAGGTCCAGAAGATATGCCTTTCACCAGCTCTATAAGACGCAAATTGGTGAGAGGGGCACCAGCACATTTGAAGGGTTTTGTTCTTTCCCTTTTCCTTGTGCCAGATCTTAGCATTGGAGAT
379 Q W E G P E D M P F T S S I R R K L V R G A P A H L K G F V L S L F L V P D L S I G D
1807 GCTTCTGCTCAATTAGATGAATTAAATTCACTGGGTTTAGTTGGATTCCGAGGTAACAAGGGCCAGGTGGCAGCATTGAATCGCCCGAGACAAGGTGATTCTAGTTATTATAATGGACAGCGTAGACAA
422 A S A Q L D E L N S L G L V G F R G N K G Q V A A L N R P R Q G D S S Y Y N G Q R R Q
1936 AAGAATGTTTATAATAACATACCCAGTAATGGTCAGCACAGGAGAGGTGAAATTTATAATGGCATGACTCGGTTGGACCTTTGGTACTGGCTAACCAATCATGGTGTTTCCAGGAATGAAATACATAGG
465 K N V Y N N I P S N G Q H R R G E I Y N G M T R L D L W Y W L T N H G V S R N E I H R
2065 AAGCCTACTGCATATTTGTTTGATCTGTATAAGCAGAAAAATTCTCAAACAAATGAAAGAAAGGCTACATTAGATCGTGGTAAACAGACAAATGAAAGAAAGGCTACATTAGATCGTGGTAAACAGCAA
508 K P T A Y L F D L Y K Q K N S Q T N E R K A T L D R G K Q T N E R K A T L D R G K Q Q
2194 TCTCGGCCAGTGAATCAATTTCCAGACTTGAGACAGTTTGCAGATCCAGAACCCCTTGAATGAAGGGGTGGCCAGGTTCCGCTGAGGAAGGATCTTGATAAGACACTCAAAGGTTTTGCTGTTACCCTT
551 S R P V N Q F P D L R Q F A D P E P L E * R G G Q V P L R K D L D K T L K G F A V T L
2323 TCTCCAGTTCTTCCCCAGAGGGACCTACGGCCTTTTACAAGGGTAACTGTACACTGGGGAAAAGGAAATAATCAGACTTTTCGGGGTCTGCTGGATACTGGTTCTGAGTTGACACTGATCCCAGGGGAT
594 S P V L P Q R D L R P F T R V T V H W G K G N N Q T F R G L L D T G S E L T L I P G D
2452 CCCAAGAAACATTGTGGCCCTCCAGTTAAAGTAGGGGCTTATGGAGGGCAGGTGATTAATGGAGTTTTGACTGATGTCCGACTCACAGTAGGTCCAGTAGGTCCCCGGACACATCCTGTGGTGATTTCC
637 P K K H C G P P V K V G A Y G G Q V I N G V L T D V R L T V G P V G P R T H P V V I S
2581 CCAGTTCCAGAATGTATAATTGGGATAGATATACTCAGAAATTGGCAGAATTCTCATATTGGTTCCCTGAACTGTAGAGTGAGGGCTATTATGGTTGGAAAGGCCAAATGGAAGCCTTTAGAGTTGCCT
680 P V P E C I I G I D I L R N W Q N S H I G S L N C R V R A I M V G K A K W K P L E L P
2710 CTGCCAAAGAAAATAGTGAATCAAAAACAGTATCGTATTCCTGGAGGAATTGCAGAAATTACTGCCACTATCAAGGACTTGAAAGATGCAGGGGTGGTGGTTCCCACCACATCTCCGTTTAACTCTCCT
723 L P K K I V N Q K Q Y R I P G G I A E I T A T I K D L K D A G V V V P T T S P F N S P
2839 ATCTGGCCAGTGCAGAAAACAGATGGATCATGGAGAATGACAGTTGATTATCGAAAACTAAATCAGGTAGTAACTCCAATTGCAGCTGCTGTACCAGATGTAGTTTCGTTACTTGAGCAAATTAACACA
766 I W P V Q K T D G S W R M T V D Y R K L N Q V V T P I A A A V P D V V S L L E Q I N T
2968 TCTCCTGGCACCTGGTATGCGGCTATTGATCTGGCAAATGCCTTCTTCTCAGTACCTGTCCATAAGGACCACCAGAAGCAATTTGCTTTCAGTTGGCAAGGCCAACAGTATACCTTCACAGTTTTGCCT
809 S P G T W Y A A I D L A N A F F S V P V H K D H Q K Q F A F S W Q G Q Q Y T F T V L P
3097 CAAGGATATATTAACTCTCCTGCCCTGTGTCATAATTTAGTTAGAAGGGATCTTGATCGTTTGGATCTTCCACAAAATATCACATTGGTGCACTATATTGATGACATTATGCTGATTGGACCAAGTGAG
852 Q G Y I N S P A L C H N L V R R D L D R L D L P Q N I T L V H Y I D D I M L I G P S E
3226 CAGGAAGTAGCAACCACTTTGGACTCATTGGTAACACATATGCGTATCAGAGGATGGGAAATAAATCCAACCAAAATTCAAGGACCATCTACCTCAGTGAAATTCTTAGGAGTCCAGTGGTGTGGGGCA
895 Q E V A T T L D S L V T H M R I R G W E I N P T K I Q G P S T S V K F L G V Q W C G A
3355 TGCAGAGATATTCCTTCTAAGGTGAAAGATAAGTTATTGCACCTGGCCCCTCCTACAACCAAGAAAGAAGCACAACGTTTAGTGGGTCTATTTGGATTCTGGAGACAACACATCCCTCACTTGGGTGTG
938 C R D I P S K V K D K L L H L A P P T T K K E A Q R L V G L F G F W R Q H I P H L G V
3484 TTACTTAGGCCTATTTACCAAGTGACTCGGAAAGCTGCTAGCTTTGTGTGGGGCCTGGAACAGGAGAAGGCCCTTCAACAGGTCCAGGCTGCTGTGCAGGCTGCTCTACCACTTGGACCATATGACCCA
981 L L R P I Y Q V T R K A A S F V W G L E Q E K A L Q Q V Q A A V Q A A L P L G P Y D P
3613 GCAGACCCGATGGTACTTGAGGTGTCTGTGGCTGATAGAGATGCTGTTTGGAGCCTCTGGCAGGCCCCTGTAGGTGAATCACAGAAAAGACCTTTGGGATTTTGGAGCAAAGCTCTACCATCATCTGCA
1024 A D P M V L E V S V A D R D A V W S L W Q A P V G E S Q K R P L G F W S K A L P S S A
3742 GACAACTATTCTCCCTTTGAAAAACAGCTCTTGGCCTGCTATTGGGCCTTAGTGGAAACTGAACGTTTGACAATAGGACACCAAGTTACTATGCGACCTGAACTACCCATCATGAGCTGGGTACTATCA
1067 D N Y S P F E K Q L L A C Y W A L V E T E R L T I G H Q V T M R P E L P I M S W V L S
3871 GACCCTGCAAGTCATAAAGTGGGACGCGCACAGCAGCAGTCTATTATCAAATGGAAGTGGTATATACGTGATCGGGCCAGAGCAGGTCCTGAAGGCACAAGCAAGTTACATGAAGAAGTTGCTCAAATG
1110 D P A S H K V G R A Q Q Q S I I K W K W Y I R D R A R A G P E G T S K L H E E V A Q M
4000 CCTATGGTTTCTACTCCTGTTACAATGCCATCTGCTGCCAAGCATGCGCCTATAGCCTCATGGGGTGTTCCCTATGATCAACTGACCGAAGAGGAGAAGACTAGAGCCTGGTTTACTGATGGCTCTGCA
1153 P M V S T P V T M P S A A K H A P I A S W G V P Y D Q L T E E E K T R A W F T D G S A
4129 CGTTATGCAGGCACCACCCAGAAGTGGACAGCTGCAGCATTACAACCCCTTTCTGGGACAACCTTGAAAGACACAGGTGAAGGGAAATCTTCACAGTGGGCAGAACTTCGGGCAGTACACATGGTATTA
1196 R Y A G T T Q K W T A A A L Q P L S G T T L K D T G E G K S S Q W A E L R A V H M V L
4258 CAGTTTGTTTGCAAGAAGAAATGGCCAGATGTACGATTATTCACTGACTCATGGGCTGTAGCCAATGGATTGGCTGGATGGTCAGGGACTTGGAAAGATCACAATTGGAAAATTGGTGAGAAAGACATC
1239 Q F V C K K K W P D V R L F T D S W A V A N G L A G W S G T W K D H N W K I G E K D I
4387 TGGGGAAGAAGTATGTGGATAGATCTCTCCAAATGGGCAAAGGATGTGAAGATATTTGTGTCCCATGTAAATGCTCACCAAAAGGTGACTTCAGCCGAGGAGGAGTTCAATAATCAAGTGGATAAGATG
1282 W G R S M W I D L S K W A K D V K I F V S H V N A H Q K V T S A E E E F N N Q V D K M
4516 ACCCGTTCTGTGGACAGTCAGCCTCTCTCCCCAGCCATCCCTGTCATTGCTCAATGGGCACATGAACAAAGTGGCCATGGTGGTCGAGATGGAGGTTATGCTTGGGCTCAGCAACACGGGCTTCCACTC
1325 T R S V D S Q P L S P A I P V I A Q W A H E Q S G H G G R D G G Y A W A Q Q H G L P L
4645 ACCAAGGCTGACCTGGCTACAGCTGCTGCTGATTGCCAGATCTGCCAACAGCAGAAACCAACACTGAGCCCCAGATATGGCACCATTCCTCGAGGTGACCAGCCAGCAACCTGGTGGCAGGTTGACTAC
1368 T K A D L A T A A A D C Q I C Q Q Q K P T L S P R Y G T I P R G D Q P A T W W Q V D Y
4774 ATTGGACCACTTCCTTCGTGGAAAGGACAGCGTTTTGTTCTTACTGGAGTAGATACTTATTCTGGTTATGGATTTGCCTTTCCTGCACGTAATGCCTCTGCTAAAACCACCATTCACGGACTGACAGAA
1411 I G P L P S W K G Q R F V L T G V D T Y S G Y G F A F P A R N A S A K T T I H G L T E
4903 TGCCTTATCTATCGTCATGGTATTCCACACAGTATTGCTTCTGACCAAGGAACTCATTTCACAGCCAGAGAAGTACGACAGTGGGCCCACGATCATGGAATTCACTGGTCTTACCACATTCCCCATCAT
1454 C L I Y R H G I P H S I A S D Q G T H F T A R E V R Q W A H D H G I H W S Y H I P H H
5032 CCTGAAGCAGCTGGTCTGATAGAAAGATGGAATGGCCTTTTGAAGACGCAGTTACAGCGCCAATTAGGTGGTAACAGCTTGGAAGGCTGGGGCAGAGTTCTTCAGAAGGCAGTATATGCTTTGAATCAG
1497 P E A A G L I E R W N G L L K T Q L Q R Q L G G N S L E G W G R V L Q K A V Y A L N Q
5161 CGCTCGATATATGGTACAGTTTCACCCATAGCCAGGATTCATGGGTCCAGGAATCAAGGGGTGGAAAACGGAATAGTTCCACTTACTATCACTCCTAGTGACCCTCTAGGAAAATTTTTGCTTCCTGTC
1540 R S I Y G T V S P I A R I H G S R N Q G V E N G I V P L T I T P S D P L G K F L L P V
5290 CCCATAACTCTAGGTTCTGCTGGCCTAGAAGTTTTGGCTCCAGAGAGGGGAGTGCTCCTACCAGGAGCTACAACAAACATTCCATTGAACTGGAAGCTCAGACTTCCCCCTGGTCATTTTGGGCTTCTA
1583 P I T L G S A G L E V L A P E R G V L L P G A T T N I P L N W K L R L P P G H F G L L
5419 ATGCCCTTAAACCAACAGGCTAAAAAAGGAATAACAGTGTTAGGAGGGGTGATAGATCCAGATTACCATGGGGAAATTGGATTACCTCTTCACAATGGTGGTAAGCAAGATTATGTCTGGAGTGTAGGA
1626 M P L N Q Q A K K G I T V L G G V I D P D Y H G E I G L P L H N G G K Q D Y V W S V G
5548 GATCCCTTAGGGCGTCTCTTAGTACTACCATGTCCTGTGATTAAAGTCAATGGGAAACTACAACAGCCTAATCCAAGCAGGATGACAAAGGACGCAGACCCATCAGGAATGAAGGTATGGGTCAATCCT
1669 D P L G R L L V L P C P V I K V N G K L Q Q P N P S R M T K D A D P S G M K V W V N P
5677 CCAGGAAAAGAGCCAAGACCTGCTGAGGTGCTGGCTGAAGGTGAAGGAAATACAGAATGGGTAGTAGAGGAAGGTAGTTATAAATACCAATTAAGGCCACGTAACCAGTTGCAGAAACGAGGATTATAA
1712 P G K E P R P A E V L A E G E G N T E W V V E E G S Y K Y Q L R P R N Q L Q K R G L *
5806 AGTAATATGAATGCCCCATTGTAAATTTACAAATGCGTTTGCGATTGTACGAGGGATAGTTATATCATGTTAGGCGTATTTACAACCTTGTTATTGTTTCATGTGAACATGAGATATTATTTGTGTCAA
5935 GTTGACAAGGGGTGGATTGTAGTGGCTATTCCTGGTTGTCAACTTGACAATATTTGGAATGAACTACAATCCGGAATTGGAAGGCTCACCAGTGACCCTTATCTGGAGGCTTGGAGATCCTTATCTGGA
6064 TCTTGGTATGGAGATCTTGAGCCATAGTGGCTATGGATTCCAGAAGATTGAATCTCCGAGTTTAAGGAACACACCTTTAATCTGGGCTACGCCTTTCATCTGGGATTAAAGGTGTGGTGGAACACACCT
6193 TTAATCTGGGCTACACCTTCTGCTGGAGACAATATAAGGACATTGGAAGAAGGGAGTCTAGCTCTAGCTCTTGCTCTTGCTCCTTCGCCTGCTTGCTGCGTGAGACTGAGTAACTGCTAGATCCTTGGA
6322 CTTCCATTCACAGCTGCGACTGAACAATTGTTGGGAATTGGGCTGCCGACTGTAAGTCATCAATAAATTCCTTTACTATCTAGAGACTATCCATAAGTTCTGTGACTCTAGAGAACCCTGACTAATACA
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Fig. 2 Nucleotide sequence and translation products of a reconstructed ancestral MuERV‑L. LTR sequences are shown in bold italics. Nucleotide and 
protein sequence of gag and pol are indicated in red and blue, respectively (amino acid single letter code, (*) represents stop codons). The 33nt dele‑
tion in gag is shown with a magenta triangle. The position of the 39nt that are deleted in some MuERV‑Ls is highlighted in magenta. The RT active 
site is highlighted in yellow. The PBS is indicated in violet, the polypurine tract in red, the TATA box in green and the polyadenylation site in bright 
blue
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Fig. 3 Reverse transcription‑dependent ancML replication. a Organization of the ancML construct. Green arrows indicate promoter sequences. 
NEO: neo gene in reverse orientation relative to ancML transcription. Chevrons indicate the orientation for each ORF (>: forward, <: reverse). A white 
box indicates a 33nt deletion in gag at position 671. b G418 resistant colonies on 15 cm cell culture plates derived from CHO cells transfected with 
plasmids expressing ancML, L1.3 or an empty vector. c Quantification of G418 resistant CHO cell colonies following transfection and treatment 
in the presence or absence AZT. CHO cells were transfected with plasmids expressing a neo gene (NEO), L1.3, ancML or an ancML construct with 
inactivating mutations in the RT active site (ancML‑RTmut). AZT treatment was applied for 2 days before G418 selection. Data are mean ± SD from 
3 independent experiments. d PCR amplification of the neo gene in genomic DNA (gDNA) extracted from CHO cells following transfection with a 
plasmid expressing ancML or an empty vector. A scheme of the PCR amplification strategy is shown on top. The use of template DNA from plasmid 
or from CHO gDNA as well as a water control is indicated. M: molecular weight ladder
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of G418 resistant colonies by the ancML and L1.3 con-
structs was modestly reduced in the presence of azi-
dothymidine (AZT), a retroviral RT inhibitor (Fig.  3c), 
while the formation of G418 resistant colonies by CHO 
cells transfected with a control plasmid expressing the 
neo gene was nearly unaffected. We isolated genomic 
DNA (gDNA) from CHO cells that had been transfected 
with the ancML plasmid and selected in G418, and deter-
mined the fate of the intron in DNA forms of ancML 
by PCR (Fig.  3d). In CHO cells transfected with the 
ancML plasmid, the vast majority of the amplified DNA 
sequences corresponded to the properly processed neo 
gene, with the intron excised (Fig. 3d).
Overall, these results indicate that the reconstructed 
ancestral MuERV-L sequence is replication competent 
and able to undergo transcription and reverse transcrip-
tion upon transfection into CHO cells.
Analysis of ancML integration in CHO cells
We next determined whether ancML underwent bona 
fide integration into CHO cell DNA. For this purpose 
we used an adapter ligation-PCR technique (Genome 
Walker kit, Clontech) to amplify integration sites using 
primers specific to the MuERV-L LTR and an adaptor 
sequence. The risk of amplifying CHO genomic DNA 
from hamster ERV-L LTR sequences was minimal as 
these LTR sequences are quite divergent from those of 
ancML (only 55.8% of sequence identity) with indels and 
substitutions in the annealing sites for the primer sets 
used. Additionally, hamster ERV-L elements exist only in 
moderate copy numbers in the Chinese hamster genome 
[52]. Therefore, DNA from G418-resistant single cell 
clones of CHO cells, previously transfected with ancML, 
was digested with restriction enzymes, ligated to linkers 
and subjected to nested PCR reactions. This procedure 
revealed bands of varying sizes, sometimes consistent 
with multiple integrations per cell (Fig.  4a). We cloned 
and sequenced some of these PCR products. Although 
some clearly resulted from amplification of the trans-
fected ancML plasmid DNA, we were able to identify 
26 bona-fide integration sites with CHO genomic DNA 
flanking the 3′ LTR (Fig. 4b and Additional file 3: Table 
S2). Amplification of sequences flanking the 5′ LTR for 
one of these integrants revealed a five-nucleotide target 
site duplication (Fig. 4b), as was observed for MuERV-L 
sequences present in the mouse genome.
Surprisingly, 10 of the 26 3′ integration sites included 
a portion of the 5′ leader sequence containing vari-
ous lengths of the primer-binding site (PBS) and a five-
nucleotide LTR-PBS linker sequence, flanking CHO 
DNA (Fig. 4b). This separation of LTR and PBS is uncom-
mon in exogenous retroviruses and has only previously 
been observed in another ERV, HERV-E [53]. Elimina-
tion of these five nucleotides in the ancML sequence 
resulted in a ~ 4 fold reduction in the number of G418 
resistant colonies, suggesting an enhancing, but non-
essential role for the five nucleotide linker in MuERV-L 
replication (Fig. 4c). Intriguingly, ~ 6.5% of the complete 
Table 2 Cell lines tested for replication of ancML
All cell lines were transfected using lipofectamine 2000
# A plasmid expressing GFP was utilized as a transfection control. Percentage of GFP positive cells: (−) 0%, (*) < 10%, (**) 10–50%, (***) > 50%
a A pCR3.1 plasmid expressing a neo gene from a SV40 promoter was used as a control for G418 resistant colony formation
b The replication dependent LINE1 (L1.3) plasmid [41] was used as a control for retrotransposition and G418 resistance from the interrupted NEO reporter cassette
c ancML correspond to a pUC57 plasmid containing the cassette depicted in Fig. 3a
Number of G418 resistant colonies: (−) None, (+) ≤ 10, (++) > 10, (+++) > 50
Cell Line Organism Lineage GFP# NEOa L1.3b ancMLc
DF‑1 Gallus gallus Aves *** +++ ++ −
CRFK Felis catus Carnivora ** +++ + −
CV‑1 Cercopithecus aethiops Primates * ++ + −
Vero Cercopithecus aethiops Primates *** +++ − +
HT1080 Homo sapiens Primates ** ++ + −
HOS Homo sapiens Primates * ++ − −
Huh7.5 Homo sapiens Primates * ++ − −
HeLa Homo sapiens Primates *** +++ ++ −
pgsA745 Cricetulus griseus Rodentia ** ++ + ++
CHO‑K1 Cricetulus griseus Rodentia ** ++ + ++
MusDunni Mus dunni Rodentia *** +++ + −
SC‑1 Mus musculus Rodentia ** ++ − −
NIH3T3 Mus musculus Rodentia ** ++ ++ −
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(LTR–gag–pol–LTR) proviruses in the mouse genome 
also contain similar sequences (5-nt linker/PBS) at 
the end of the 3′ LTR, thus showing that this phenom-
enon also occurred during ancient MuERV-L replication 
events (Additional file 1: Table S1). During reverse tran-
scription, after the synthesis of the plus-strand strong-
stop DNA (+sssDNA), RNase H should remove the 
primer tRNA, thereby exposing sequences on the +sss-
DNA that are complementary to the minus strand PBS 
which will guide the second strand transfer [54, 55]. Inef-
ficient removal of the tRNA primer might result in the 
synthesis of +sssDNA that includes additional sequences 
3′ to the PBS. Such a scenario might explain the unusual 
integration site structure that we observed for some 
MuERV-L and ancML insertions (Fig. 4b).
We mapped the position of the 26 ancML integration 
sites to the Chinese hamster genome using the UCSC 
genome browser (Fig. 4d) [35, 47]. The Chinese hamster 
genome (CriGri_1.0) is currently assembled to the scaf-
fold level and has been annotated by distinct de novo, 
expression-based and homology gene prediction systems 
[35]. The majority of the ancML integration sites (19/26 
sites) corresponded to intergenic regions, 5/26 sites cor-
responded to introns and one corresponded to exon 3 of 
Znf462. The single remaining site could not be classified 
as intergenic or in genes because it mapped to multiple 
b
dc
a
Fig. 4 Integration of ancML into CHO cell DNA. a Example of a genome walker experiment to determine the 3′ flanking sequence of ancML 
integration events in 15 single cell clones that became resistant to G418 following transfection with ancML. Nested PCR reactions were done 
using EcoRV digested, adapter ligated, gDNA from single G418‑resistat cell clones. Forward and reverse primers were designed to anneal to the R 
region of the 3′LTR and to the adaptor sequence, respectively. M: molecular weight ladder. u: CHO DNA without an integrated ancML insertion. b 
Top: the sequence of an integration site with both 5′ and 3′ flanking CHO gDNA. The five‑nucleotide target site duplication is indicated in yellow. 
Bottom: Sequences of 26 ancML integration sites in the CHO genome. Sequences of the ancML U5‑PBS region as well as the Leucine (TAA) tRNA 
sequence are included at the bottom of the diagram. Sequence from the U5 region of the 3′ ancML LTR is indicated in blue. The 5nt linker sequence 
is indicated in black. The PBS sequence is indicated in purple. CHO genomic sequences are indicted in bold. Dotted lines indicate correspondence 
of each sequenced 3′ integration junction to the integration site at the top. c Enumeration of G418 resistant colonies of CHO cells transfected with 
plasmids expressing a neo gene (NEO), L1.3, ancML and an ancML construct with a deletion of the 5nt linker sequence between the 5′ LTR and 
the PBS (ancML ∆GAAGT). Data are mean ± SD from 3 independent experiments. d Distribution of ancML integration sites in genic, intergenic, or 
repeat regions relative to matched random controls. The measured value indicates the percentage of ancML integration sites in each population 
divided by that of the matched random controls (each integration site was matched to three random genomic sequences equidistant to the EcoRV 
site where the adaptor was ligated). The horizontal dashed line indicates no difference between the frequencies of ancML integration sites in each 
population compared to the matched controls
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scaffolds. Of the 26 integration sites, 10 were in elements 
corresponding to SINE (4), LINE (4) and ERV-L (2) ele-
ments. This distribution of ancML integration sites, i.e. 
within genes versus intergenic regions, as well as within 
versus outside repetitive sequences, did not differ signifi-
cantly from matched randomized controls (p value = 0.97 
and 0.56 respectively) (Fig.  4d). Although the distribu-
tion of the sequenced ancML integration sites and the 
distribution of MuERV-L elements in the mouse genome 
appeared different (Figs. 1d and 4b), our ancML integra-
tion site dataset was too small to establish statistical sig-
nificance. Nonetheless, our results suggest that ancML 
integration sites are random (or close to random) in their 
distribution in CHO DNA, in contrast to the distribu-
tion of MuERV-L proviruses that are found in the mouse 
genome which have been subject to selection.
ancML is sensitive to innate host antiviral defenses
In response to exogenous microbial threats, hosts have 
evolved sets of genes that sense, and directly interfere 
with replication of pathogens. One class of such genes 
which are expressed in response to viral infection fol-
lowing induction by interferons (IFNs), cause a so-called 
antiviral state [56]. It is not known whether IFNs can 
inhibit the intracellular replication of retrotransposons. 
To determine whether ancML replication is affected by 
type-I IFNs, we transfected CHO cells with plasmids 
expressing ancML, L1.3 or a neo gene and cultured them 
with media containing varying amounts of murine IFNα 
(mIFNα) for 2  days prior to selection in G418 (Fig. 5a). 
The replication of L1.3 was reduced by ~ 4 fold upon 
mIFN-α treatment, and there was a larger, dose depend-
ent effect on ancML, reaching a ~ 20-fold reduction in 
G418 resistant colony formation with 50U/ml of mIFNα 
(Fig.  5a). Notably, generation of G418-resistant colonies 
by transfected, non-replicated DNA was not affected by 
mIFNα. Previous studies have observed that mouse IFNα 
can stimulate an antiviral state in CHO cells [57–60] and 
promote the induction of hamster ISGs [61]. Thus, these 
experiments suggest that IFNα is able to inhibit one or 
more steps in MuERV-L replication. Interestingly pluri-
potent stem cells have been shown to express a subset 
of ISGs [62], and suppression of ERV replication may be 
one impetus for the acquisition of this property.
We also tested whether specific candidate innate 
immune effectors could inhibit ancML replication. We 
first tested if the murine restriction factor Fv1 (thought to 
have been co-opted from a MuERV-L-like element) could 
have had an impact on MuERV-L replication. For this 
we constructed CHO cells stably expressing a chimeric 
form of Fv1 that shows an expanded resistance to differ-
ent MuLVs  (Fv1bbn) [63]. As expected,  Fv1bbn-expressing 
CHO cells exhibited resistance to infection by both 
N-tropic and B-tropic MuLV (Fig.  5b). However, 
 Fv1bbn-expressing CHO cells supported ancML, or L1.3 
replication (Fig. 5c), at levels similar to those of control 
cells, indicating that ancML is insensitive to this Fv1 
protein. We also tested the ability of mouse APOBEC3, 
that has been previously shown to inhibit endogenous 
and exogenous retroviruses (reviewed in [64]), to inhibit 
ancML replication. For this purpose, we generated CHO 
cell clones that stably expressing the mouse Apobec3 in 
100% of the cells (Fig.  5d). Remarkably, mouse Apobec3 
(mA3) was able to inhibit ancML replication, reducing 
G418 resistant colony formation by ~ 30-fold, but did not 
affect L1.3 replication (Fig.  5e). The inability of mA3 to 
(See figure on next page.) 
Fig. 5 MuERV‑L(ancML) replication can be inhibited by innate immune effectors. a Enumeration of G418 resistant colonies generated in the pres‑
ence of increasing amounts of mouse IFNα. CHO cells were transfected with plasmids expressing a neo gene (NEO), L1.3, or ancML and cultured with 
increasing amounts of mouse IFNα for 2 days before G418 selection. Data are mean ± SD from 3 independent experiments. b Infectivity of MuLV on 
CHO cells expressing  Fv1bbn. Percentage of MuLV infected (GFP positive) cells in CHO cells stably expressing  Fv1bbn (red) or an empty vector (black). 
Circles and triangles indicate infection by N‑tropic or B‑tropic MuLV, respectively. c Enumeration of G418 resistant colonies of CHO cells expressing 
 Fv1bbn or an empty vector were transfected with plasmids expressing a neo gene (NEO), L1.3, or ancML. Data are mean ± SD from 2 independent 
experiments. d Representative images of Immunofluorescence assays on CHO cells stably expressing an HA‑tagged version of mouse APOBEC3 
or an empty vector. CHO cells were fixed with 4% PFA and stained with anti‑HA antibodies. e Enumeration of G418 resistant colonies of CHO cells 
expressing mouse APOBEC3. Three clones of CHO cells expressing HA‑tagged mA3 or an empty vector were transfected with plasmids expressing a 
neo gene (NEO), L1.3, or ancML. Data are mean ± SD from 3 experiments with independent single cell clones. f and g Analysis of MuERV‑L elements 
using Hypermut 2.0. Ratio of G to A mutations at preferred mA3 editing sites (RD 3′ to a G) (Y‑axis) plotted against ratio of G to A mutations at dis‑
favored mA3 editing sites (YN|RC 3′ to a G) (control ratio, X‑axis). No 5′ context was imposed (f), or sites with a 5′ C to the mutated G were excluded 
(g). 230 gag–pol containing MuERV‑L elements in the mouse genome were compared to their consensus sequence. Data points in red and orange 
indicate MuERV‑L sequences that were statistically significantly enriched in putative mA3 induced mutations (p value < 0.05). Data points in orange 
represent MuERV‑L elements that are statistically significantly enriched mA3‑induced mutations in both analyses (p value < 0.01). h Profile of G to 
A transitions in two putatively mA3‑edited MuERV‑L proviral sequences compared to a consensus sequence. The profile of the reference MuERV‑L 
sequence is shown for comparison  (MLref, non significantly mA3 edited). Lines in red and cyan represent putative mA3‑derived G to A transitions, not 
accounting for the + 2 position (dinucleotide changes from GG to AG and GA to AA respectively), whereas lines in green and magenta represent non 
mA3‑derived G to A transitions (GC to AC and GT to AT respectively). Lines in yellow indicate gaps compared to the consensus sequence
Page 13 of 17Blanco‑Melo et al. Retrovirology  (2018) 15:34 
d
a
e
f
cb
g
h
Page 14 of 17Blanco‑Melo et al. Retrovirology  (2018) 15:34 
restrict human L1.3 retrotransposition has been previ-
ously documented [65], while some human APOBEC3 
proteins inhibit L1.3 retrotransposition [42, 66, 67], sug-
gesting that species-dependent differences exist in the 
ability of APOBEC3 proteins to inhibit the replication of 
endogenous retroelements.
Because mA3 clearly inhibited ancML replication, and 
therefore might have affected MuERV-L sequence or rep-
lication in vivo, we inspected the 230 gag–pol containing 
MuERV-L elements that were used to derive ancML gag 
(Fig.  1f ) using Hypermut 2.0 [40] (Fig.  5f–h). For each 
MuERV-L element we compared the number of G to A 
transitions in mA3-preferred motifs (5′ G(A|G)(A|G|T) 
3′) with those in control sites (5′ G(C|T)N 3′ or 5′ G(A|G)
C 3′) relative to a consensus sequence (Additional file 4: 
Table S3). Only three MuERV-L elements showed signifi-
cant (p < 0.05) evidence of mA3 dependent hypermuta-
tion when no 5′ context was enforced (Fig. 5f ). Because 
spontaneous deamination of methylated CpG dinucleo-
tides can also produce G to A transitions, we performed 
the same analysis after excluding sites containing a C 
nucleotide 5′ to the mutated G. When these sites were 
excluded, 10 MuERV-L elements showed a significant 
(p < 0.05) evidence for mA3 dependent hypermutation 
(Fig.  5g). Only two MuERV-L elements exhibited statis-
tically significant evidence of mA3 dependent hyper-
mutation in both analyses (p value < 0.01), and both of 
these elements carried a relatively low mutational bur-
den (Fig.  5f–h). Thus, although ancML replication can 
be inhibited by mA3, analysis of MuERV-L proviruses in 
the mouse genome suggests that MuERV-L either rarely 
encountered mA3, or is inhibited in a manner that pre-
vents the deposition of hypermutated proviruses.
Discussion
Here, we report the successful reconstruction of a ~ 2MY 
old replication competent ancestral MuERV-L sequence, 
through the analysis of a recently expanded subset of fos-
silized MuERV-L elements in the mouse genome. Accord-
ing to previous studies [16], and corroborated here, 
MuERV-L originated ~ 10 MYA, after the Rattus–Mus 
split and underwent a prolific expansion ~ 2 MYA. In fact, 
almost 65% of solo LTRs and MuERV-L proviruses identi-
fied herein have an estimated integration date of < 3 MYA. 
Furthermore, the estimated dates of solo LTRs follow a 
bimodal distribution (a major one centered ~ 3MYA and 
the other ~ 8MYA) consistent with the estimated times of 
both expansions (Additional file 1: Table S1). A combina-
tion of homology searches and defragmentation methods 
provided the material for the estimation of the sequence 
of the ~ 2MY old replication-competent ancestor.
Other highly abundant env-defective ERVs typically 
appear to be derived from closely related elements that 
possess an env gene. While other closely related elements 
do possess an env gene, there are no documented ERV-L 
elements that encode an env. It is likely, therefore, that 
an ancestral ERV-L element lacked an env gene. Thus, 
the bulk of MuERV-L replication likely occurred through 
entirely intracellular retrotransposon-like mechanisms 
[21]. Moreover, the bulk of MuERV-L replication likely 
occurred in early embryos, as the expression of MuERV-
L elements appears to be restricted to the 2-cell embryo, 
although It is unknown whether this property is confined 
to the subset of elements that proliferated ~ 2MYA. It is 
possible that the early embryonic environment is also nec-
essary in some other way for MuERV-L replication given 
its apparently restricted tropism in cell lines. In particular, 
it is intriguing that (and as yet unexplained why) MuERV-
L only replicated with reasonable efficiency in Chinese 
hamster ovary cells, even when provided with a promoter 
that should drive its expression in nearly any cell type.
MuERV-L belongs to an ancient mammalian ERV fam-
ily (which originated > 100 MYA [18]) that is distantly 
related to spumaviruses. Therefore, modern functional 
viral sequences are therefore not useful for attempts to 
increase the replicative efficiency of ancML. Remarkably, 
there is a high number of MuERV-L proviruses that have 
retained their coding potential, and share a high degree 
of sequence similarity to the functional ancML (with only 
few coding differences and overall nucleotide identity 
ranging from 96.16 to 99.31%). However, currently there 
is no evidence that the ongoing expression of MuERV-
L elements at the two-cell stage of the mouse embryo 
results in successful re-integration, although it is possi-
ble that MuERV-L replication and reintegration occurs in 
modern mouse embryos at some very low rate. Neverthe-
less, examination of recent bona fide integrations might 
highlight important residues that might be altered to 
improve ancML replication and/or integration.
We found that mouse IFNα was able to inhibit ancML 
replication, suggesting that interferon stimulated genes 
can directly inhibit MuERV-L replication, possibly lead-
ing to its recent extinction as a replication competent 
entity. Alternatively, early embryos may express antiviral 
proteins that inhibit re-integration of modern MuERV-L 
elements that would otherwise be intrinsically replication 
competent [62]. We found that mouse APOBEC3 inhibits 
ancML replication, but mutational profiles of MuERV-L 
elements in the mouse genome provide minimal evidence 
for mA3-dependent hypermutation as a mechanism for 
inhibition in  vivo. During mouse development, mA3 is 
expressed at the two-cell stage, increasing at the four-cell 
stage to become one of the top 30% most highly expressed 
genes [68]. Thus, it is at least possible that mA3 may have 
acted on replicating MuERV-L elements, perhaps in part 
through deaminase-independent mechanisms [69].
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Despite the apparently random integration pattern 
of ancML, the analysis of fixed MuERV-L elements 
showed that there has been a selective pressure to elimi-
nate MuERV-L integrations from genes. Conversely, 
MuERV-L related sequences (Fv1) have clearly been 
positively selected to provide defense against retroviral 
infection [22–24] and recent studies have suggested that 
regulatory elements of MuERV-L LTRs may have been 
co-opted to regulate the expression of numerous genes 
during embryogenesis [14, 15]. While Fv1 arose at least 
~ 5–7 MYA, it is unclear whether the potential exapta-
tion of MuERV-L regulatory sequences occurred dur-
ing the 10MYA expansion or the more recent ~ 2 MYA 
expansion. Nonetheless, there appears to be both a ben-
efit (co-option for antiviral defense and regulation of 
embryogenesis) and cost (disruption of gene function) 
associated with the presence of MuERV-L elements in 
the mouse genome.
MuERV-L appears to be the only member of the ERV-L 
family that seems to have been reactivated in recent 
evolutionary times. It is particularly intriguing that the 
recent expansion is characterized by an in-frame dele-
tion in gag, as it could be this deletion the responsible 
for releasing some MuERV-L elements from the delete-
rious effects of a hypothetical inhibitory factor ~ 2MYA. 
Recent studies have shown the fundamental role that 
some endogenous retroviral sequences may play in mam-
malian development and protection from exogenous ret-
roviral infection [15, 23, 24, 70–73]. Indeed one report 
has suggested that knockdown of MuERV-L transcripts 
impacts embryonic development [74]. Nevertheless, it 
remains to be determined whether the current presence 
of MuERV-L transcripts, proteins and virus-like particles 
at the two-cell stage of the mouse embryo might be ben-
eficial or deleterious to the mouse.
Conclusions
The reconstruction of an ancestral MuERV-L sequence 
highlights the potential for the retroviral fossil record to 
illuminate ancient events and represents a unique oppor-
tunity to study ERV-L biology and reactivation, the role 
of MuERV-L in mouse development and potentially 
uncover new roles for ERVs in mammalian biology.
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